Pfizer is a global pharmaceutical company and among the top pharmaceutical companies in the world. Pfizer is headquartered in New York City. In 2021, the company's total revenue was about 81 billion U.S. dollars. This is a significant increase compared to to all previous years and is, of course, a consequence of the record-breaking sales of COVID-19 vaccine Comirnaty.
Pfizer’s global positioning
Pfizer’s products are available in many countries worldwide and as of 2021 the company had 170 research and development projects in the pipeline. For several years, Pfizer was the top pharmaceutical company based on global prescription drug sales and is among the leading pharmaceutical companies based on research and development (R&D) spending. Pfizer’s largest segment is Innovative Health (IH). The Innovative Health business focuses on various rare diseases, vaccines, immunology and internal medicine to name a few.
Pfizer’s top products
Pfizer has several products that are quite popular. In 2021, products from the Prevnar family were among their top products based on revenue. However, Pfizer has several other drugs that are also well known. For example, Lipitor (atorvastatin calcium) is used in the treatment of high cholesterol. Over the years, however, Lipitor revenues have been on the decline, yet it remains part of Pfizer’s top products. One of Pfizer’s most well-known products, Viagra (sildenafil citrate), used in the treatment of erectile disfunction, has also been on the decline with 2019 having the lowest revenues on record. The low revenues are mainly attributable to Viagra’s loss of patent exclusivity in the U.S. in December 2017.
Pfizer's total revenue from 2006 to 2021
(in million U.S. dollars)
This statistic was assembled from several editions of Pfizer's annual financial report.
* Amount reflects the Upjohn Business and the Mylan-Japan collaboration as discontinued operations in all periods presented following the November 16, 2020 spin-off and combination of the Upjohn Business with
Mylan and the December 21, 2020 termination of the Mylan-Japan collaboration. Previous years have not been restated.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Pfizer. (February 24, 2022). Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 16, 2022, from https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/
Pfizer. "Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars)." Chart. February 24, 2022. Statista. Accessed May 16, 2022. https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/
Pfizer. (2022). Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 16, 2022. https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/
Pfizer. "Pfizer's Total Revenue from 2006 to 2021 (in Million U.S. Dollars)." Statista, Statista Inc., 24 Feb 2022, https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/
Pfizer, Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars) Statista, https://www.statista.com/statistics/266171/revenue-of-pfizer-since-2006/ (last visited May 16, 2022)